{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:18:34Z","timestamp":1793204314980,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1001\/jamaneurol.2018.0629","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T12:30:32Z","timestamp":1525091432000},"page":"970","source":"Crossref","is-referenced-by-count":216,"title":["Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting"],"prefix":"10.1001","volume":"75","author":[{"given":"Rosebud O.","family":"Roberts","sequence":"first","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah A.","family":"Aakre","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kremers","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vassilaki","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabe","family":"Alhurani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas E.","family":"Geda","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Psychiatry and Psychology and Neurology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Machulda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preciosa","family":"Coloma","sequence":"additional","affiliation":[{"name":"Real World Data Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schauble","sequence":"additional","affiliation":[{"name":"Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"noi180021r1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria.","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi180021r2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria.","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi180021r3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi180021r4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"20","key":"noi180021r5","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"noi180021r6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","article-title":"Mild cognitive impairment due to Alzheimer disease in the community.","volume":"74","author":"Petersen","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"noi180021r7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u00df-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol"},{"issue":"19","key":"noi180021r8","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"issue":"19","key":"noi180021r9","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"noi180021r10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","article-title":"Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community.","volume":"73","author":"Petersen","year":"2016","journal-title":"JAMA Neurol"},{"issue":"16","key":"noi180021r11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints.","volume":"81","author":"van Harten","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"noi180021r12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study.","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi180021r13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline.","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"issue":"3","key":"noi180021r14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization.","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"noi180021r15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"10","key":"noi180021r16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1212\/WNL.0b013e3181f11d85","article-title":"Prevalence of mild cognitive impairment is higher in men.","volume":"75","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"noi180021r17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"noi180021r18","article-title":"Mayo\u2019s older Americans normative studies: WAIS-R norms for ages 56 to 97.","author":"Ivnik","year":"1992","journal-title":"Clin Neuropsychol"},{"issue":"3","key":"noi180021r19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jim.2004.256.issue-3","article-title":"Mild cognitive impairment as a diagnostic entity.","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"issue":"7","key":"noi180021r21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"noi180021r22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"18","key":"noi180021r23","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/WNL.0000000000000386","article-title":"Rates of \u00df-amyloid accumulation are independent of hippocampal neurodegeneration.","volume":"82","author":"Jack","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"noi180021r24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.neuroimage.2005.02.005","article-title":"Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease.","volume":"26","author":"Senjem","year":"2005","journal-title":"Neuroimage"},{"issue":"5","key":"noi180021r25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"noi180021r26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease.","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"noi180021r27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/oxfordjournals.epirev.a036176","article-title":"Advances in strategies for minimizing and adjusting for survey nonresponse.","volume":"17","author":"Kessler","year":"1995","journal-title":"Epidemiol Rev"},{"issue":"451","key":"noi180021r28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/01621459.2000.10474263","article-title":"Estimating and using propensity scores with partially missing data.","volume":"95","author":"D\u2019Agostino","year":"2000","journal-title":"J Am Stat Assoc"},{"key":"noi180021r29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2307\/1403140","article-title":"Survey nonresponse adjustments for estimates of means.","volume":"54","author":"Little","year":"1986","journal-title":"Int Stat Rev"},{"issue":"5","key":"noi180021r30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3182452862","article-title":"The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.","volume":"78","author":"Roberts","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"noi180021r31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","article-title":"A European multicentre PET study of fibrillar amyloid in Alzheimer\u2019s disease.","volume":"40","author":"Nordberg","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"noi180021r32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ana.24040","article-title":"Predicting Alzheimer disease with \u00df-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.","volume":"74","author":"Rowe","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"noi180021r33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study.","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol"},{"issue":"22","key":"noi180021r34","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons.","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMA"},{"key":"noi180021r20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","edition":"4th ed"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2679318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T06:30:46Z","timestamp":1604212246000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.0629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.0629","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}